source
- BMS flags liver injury cases, including a death, in Phase 3 trial of pulmonary fibrosis drug admilparantBristol Myers Squibb has amended the protocol for its Phase 3 pulmonary fibrosis study of admilparant after reporting several liver injury events, one of which resulted in a patient death. The comp…
- Roche Diagnostics unveils single-assay newborn test for SMA, SCID and Sickle Cell DiseaseRoche Diagnostics introduced a new in‑vitro diagnostic kit called LightMix Newborn TREC/SMN1/HBB that can screen newborns for three rare genetic disorders in a single test. The assay simultaneousl…